• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Diversified Healthcare Trust Elects Alan Felder to Board of Trustees

    3/20/25 4:15:00 PM ET
    $DHC
    $RMR
    Real Estate Investment Trusts
    Real Estate
    Professional Services
    Consumer Discretionary
    Get the next $DHC alert in real time by email

    Diversified Healthcare Trust (NASDAQ:DHC) today announced that it has elected Alan Felder to its Board of Trustees as an Independent Trustee, effective immediately.

    Alan Felder previously worked at UBS Investment Bank for over 20 years, where he most recently served as the Head of Real Estate, Lodging and Leisure, Americas. Mr. Felder previously held other roles at UBS, including Head of Private Financing Markets, Americas and a Managing Director in the Mergers and Acquisitions Group. Prior to joining UBS Investment Bank, Mr. Felder worked in investment banking at Donaldson Lufkin & Jenrette, focusing on capital markets and M&A transactions. He graduated from the Wharton School of the University of Pennsylvania. Mr. Felder will serve on DHC's Audit Committee.

    Korn Ferry assisted DHC's Nominating and Governance Committee in placing Alan Felder on DHC's Board of Trustees.

    About Diversified Healthcare Trust

    DHC is a real estate investment trust focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location. As of December 31, 2024, DHC's approximately $7.2 billion portfolio included 367 properties in 36 states and Washington, D.C., occupied by approximately 450 tenants, and totaling approximately 8.0 million square feet of medical office and life science properties and more than 27,000 senior living units. DHC is managed by The RMR Group (NASDAQ:RMR), a leading U.S. alternative asset management company with over $40 billion in assets under management as of December 31, 2024 and more than 35 years of institutional experience in buying, selling, financing and operating commercial real estate. DHC is headquartered in Newton, MA. For more information, visit www.dhcreit.com.

    A Maryland Real Estate Investment Trust with transferable shares of beneficial interest listed on the Nasdaq.

    No shareholder, Trustee or officer is personally liable for any act or obligation of the Trust.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250320284812/en/

    Bryan Maher, Senior Vice President

    (617) 796-8234

    Get the next $DHC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DHC
    $RMR

    CompanyDatePrice TargetRatingAnalyst
    The RMR Group Inc.
    $RMR
    4/22/2025$24.00Buy
    B. Riley Securities
    Diversified Healthcare Trust
    $DHC
    4/3/2025$4.50Buy
    B. Riley Securities
    The RMR Group Inc.
    $RMR
    4/19/2024Mkt Perform
    JMP Securities
    The RMR Group Inc.
    $RMR
    8/9/2022Perform
    Oppenheimer
    The RMR Group Inc.
    $RMR
    1/5/2022$43.00 → $39.00Equal-Weight
    Morgan Stanley
    Diversified Healthcare Trust
    $DHC
    12/30/2021$5.00 → $6.00Buy
    B. Riley Securities
    The RMR Group Inc.
    $RMR
    10/22/2021$38.00Neutral
    Citigroup
    The RMR Group Inc.
    $RMR
    8/31/2021$41.00 → $43.00Equal-Weight
    Morgan Stanley
    More analyst ratings